Managing weight or diabetes is often overwhelming, especially when faced with the ever-expanding array of medication options. And with Zepbound, the newest in town, being launched recently, things just got a little shaken again. Zepbound, Mounjaro, Wegovy, Ozempic... these cutting-edge injections share many similarities, but they also have their own specificities.
Choosing one over the other isn’t just about understanding what these drugs do; it's also about knowing what impact they’ll have on your life.
So, let’s try bringing a bit of clarity to your choices and help you feel better informed and empowered before your next visit to the doctor.
Related article: Zepbound: A Complete Guide About the Newest Weight-Loss Drug.
Zepbound vs. Mounjaro
Let’s start by comparing Zepbound and Mounjaro, two injections manufactured by the same company, Eli Lilly, and containing the same ingredient, Tirzepatide.
Same active ingredient
Tirzepatide, the active ingredient found in both Zepbound and Mounjaro, is the very first dual agonist drug for both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors.
By activating both GIP and GLP-1 receptors simultaneously, tirzepatide effectively helps control blood sugar levels, improve insulin sensitivity, reduce appetite, and boost metabolism functions at the same time.
This dual-action mechanism is a key distinguishing feature of tirzepatide, setting it apart from other weight-loss and diabetes drugs, like Ozempic or Wegovy, that can target only one of these two hormones and, therefore, only one aspect of metabolic regulation.
Zepbound utilizes this mechanism primarily for weight loss by reducing appetite and improving metabolic function, whereas Mounjaro leverages it for glycemic control in Type 2 diabetes, with weight loss as a beneficial side effect.
Both Zepbound and Mounjaro are prescription drugs and can only be delivered with medical prescription and under medical supervision. As mentioned above, they are technically the same drug, Tirzepatide. But their clinical trials and FDA-approvals differ.
- Zepbound is prescribed for chronic weight management in adults with a BMI of 30 kg/m² or higher, or in overweight adults (BMI of 27 kg/m² or higher) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
- Mounjaro is FDA-approved for type 2 diabetes only. However, because it leads to significant weight loss as a side effect, Mounjaro used to be prescribed off-label for weight loss in adults with or without type 2 diabetes.
Clinical efficacyZepbound has been clinically shown to provide substantial weight loss, with an average of 15-18% of body weight loss over 72 weeks of treatments. According to Eli Lilly, the manufacturer, “1 in 3 people taking the 15-mg dose of Zepbound lost over 58 lbs”.
Mounjaro, while also effective in weight loss due to its impact on metabolism and appetite, has been primarily studied for its efficacy in improving blood sugar levels in type 2 diabetes patients.
Same administrationBoth Zepbound and Mounjaro are administered as a weekly subcutaneous injection. The injector pens are the same and work similarly.
They are both available in different strength, including 2,5 mg, 5 mg, 7,5 mg, 10 mg, 12,5 mg, and 15 mg. The dose generally starts at the lower level, but the dosing protocols for both drugs may be gradually increased, as recommended by your doctor.
Similar side effectsBoth Zepbound and Mounjaro share a similar side effects profile due to their common active ingredient (Tirzepatide).
Common side effects include gastrointestinal issues such as nausea, diarrhea, and constipation, as well as injection site reactions. However, the intensity and occurrence of these side effects may vary between the two drugs, given their different target populations and treatment goals. Both drugs can also cause more serious, although less common, side effects such as pancreatitis or kidney problems.
Always consult with your doctor for a complete understanding of possible side effects and an evaluation of the benefits vs. risks ratio in your own individual situation.
Related article: Wegovy vs. Mounjaro: Understanding the Differences in Diabetes & Obesity.
Zepbound vs. WegovyNow, since its launched in November 2023, Zepbound is often compared to Wegovy, which was considered the most effective weight-loss injection, until now.
Different active ingredientsAs mentioned above, Zepbound contains Tirzepatide. But Wegovy is formulated with a different ingredient, Semaglutide. Therefore, while they are both weight-loss injection drugs, they work differently.
We’ve already seen that Zepbound (Tirzepatide) is a dual agonist for both GIP and GLP-1 receptors. But Wegovy, on the other hand, focuses on activating GLP-1 receptors only, which leads to appetite suppression and a resultant decrease in caloric intake, but has no effects on insulin sensitivity ad blood sugar levels.
Similar FDA-approvalsBoth Zepbound and Wegovy are approved for similar patient profiles. Zepbound is indicated for chronic weight management in adults with a BMI of 30 kg/m² or higher, or those with a BMI of 27 kg/m² or more who also have weight-related health conditions.
Similarly, Wegovy is intended for adults meeting the same BMI criteria and is also suitable for those with at least one weight-related condition. There’s a slight difference though, with Wegovy being approved for pediatric patients aged 12 or more diagnosed with obesity, while Zepbound isn’t approved for children.
Zepbound is more efficient than WegovyBecause of their similar FDA-approvals and patient profile, an important thing to consider when choosing between Wegovy and Zepbound is their respective efficacy.
Until Zepbound’s approval, Wegovy was considered the most effective weight-loss injection. However, Zepbound has displayed even more impressive results in clinical trials. But always keep in mind that, Zepbound being clinically more efficient does not necessarily mean it’s best for you. Efficacy is an important factor to consider, but it’s not the only one.
Similar administration protocolsZepbound and Wegovy are both administered via weekly subcutaneous injections. They both come in prefilled, single-use, injector pens that are easy to use.
Their respective protocols are quite similar, with dosages starting low and gradually increasing based on tolerance and response to the treatment.
Related article: A Step-by-Step Guide to Using Zepbound Injector Pen.
Side effectsZepbound and Wegovy share common side effects, such as gastrointestinal issues (primarily nausea, vomiting, and diarrhea). Injection site reactions and general symptoms like fatigue or headaches can also occur with both medications.
Both Wegovy and Zepbound can also cause serious side effects, such as gallbladder disease or pancreatitis, and others. When choosing between Wegovy and Zepbound for your new weight-loss treatment, it’s very important that you talk with your doctor about all potential side effects and consider which medication is the safest for you, taking into account your medical history and personal situation.
In summary, Zepbound and Wegovy do have overlapping purposes in weight management and similar administration and side effect profiles. While Zepbound seem to be more effective with a more significant weight loss, it does not necessarily mean it’s the best for you. The choice between these two medications must be based on a comprehensive medical evaluation, treatment goals, and potential side effects with your healthcare provider.
Related article: Wegovy vs. Mounjaro: Understanding the Differences in Diabetes & Obesity.
Zepbound vs. OzempicAnd last, let’s compare Zepbound and Ozempic, two different injections, used for different purposes, but with somewhat similar effects.
Different active ingredientsZepbound and Ozempic aren’t the same drug. Zepbound is formulated with Tirzepatide, known for its dual action on both GLP-1 and GIP hormone receptors. On the other hand, Ozempic contains Semaglutide, a drug primarily targeting GLP-1 receptors, which play a significant role in glucose regulation and appetite suppression, making it a valuable tool in managing Type 2 diabetes and aiding in weight loss as a secondary benefit.
Different FDA-approvalsAs you now know, the FDA has approved Zepbound for chronic weight management in adults with obesity, indicated by a BMI of 30 kg/m² or higher, or in overweight adults with a BMI of 27 kg/m² or more who have associated weight-related health issues.
Ozempic, while also used off-label for weight loss, is primarily prescribed for the management of Type 2 diabetes.
Clinical efficacyZepbound is currently considered the most efficient weight-loss injection. Ozempic isn’t a weight-loss drug, as it primarily aims at improving blood sugar levels in diabetic patients. However, it has also been noted for its weight loss properties, though its focus remains diabetes management.
Similar administrationBoth Zepbound and Ozempic are administered through weekly subcutaneous injections. They both come in prefilled injector pens. The Zepbound pen is single dose and ready to use, while the Ozempic pen contains 4 doses of medications, worth a month of treatment, and must be used with disposable needles.
Side effectsSide effects for Zepbound and Ozempic are somewhat similar due to their shared mechanism of actionthrough GLP-1 receptor activation. Common side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Both medications can also cause reactions at the injection site. However, while both medications have similar side effect profiles, serious side effects may vary between the two and must be considered with the help of your doctor and regarding your personal situation.
Related article: Mounjaro vs. Ozempic: Comparison in Diabetes and Weight Loss Therapy.
Navigating your choices with careDeciding between Zepbound, Mounjaro, Wegovy, and Ozempic can feel a bit like navigating a maze – each path offers different benefits and suits different needs. It's not just about what works best on paper; it's about what works best for you.
These drugs often overlap in their actions. And considering the close links between diabetes and weight, many people may be eligible for all of them.
The key to making this decision lies in a heart-to-heart conversation with your doctor, who can translate the technical language of 'clinical efficacy' and 'mechanisms of action' into something that makes sense for your life, your body, and your health goals.
Think of your lifestyle, too. Consider side effects not just as a list in a pamphlet, but in terms of how they might impact your day-to-day life. And remember, managing weight or diabetes is often a marathon, not a sprint– so taking time to choose the right drug for you is worth it.
So, as you stand at this crossroads, take a deep breath. You're not just choosing a medication; you're choosing a partner in your health journey.